MBCOF (Marvel Biosciences) Other Current Receivables: $0.02 Mil (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Other Current Receivables?

Marvel Biosciences MBCOF 34 Other Current Receivables is $0.02 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's Other Current Receivables for the quarter that ended in Apr. 2026 was $0.02 Mil.

Marvel Biosciences's quarterly Other Current Receivables declined from Oct. 2025 ($0.02 Mil) to Jan. 2026 ($0.01 Mil) but then increased from Jan. 2026 ($0.01 Mil) to Apr. 2026 ($0.02 Mil).

Marvel Biosciences's annual Other Current Receivables increased from Jul. 2023 ($0.06 Mil) to Jul. 2024 ($0.09 Mil) and increased from Jul. 2024 ($0.09 Mil) to Jul. 2025 ($0.12 Mil).

Marvel Biosciences Other Current Receivables Related Terms

Marvel Biosciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Other Current Receivables Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Other Current Receivables
Get a 7-Day Free Trial 0.05 0.04 0.06 0.09 0.12

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.12 0.02 0.01 0.02
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.02 Mil mean?
Marvel Biosciences (MBCOF) has a Other Current Receivables of $0.02 Mil as of Apr. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' Other Current Receivables too high?
Marvel Biosciences' current Other Current Receivables is $0.02 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Other Current Receivables compare to VRTX and REGN?
Marvel Biosciences' Other Current Receivables of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current Other Current Receivables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Other Current Receivables of $0.02 Mil. The current Other Current Receivables is $0.02 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Other Current Receivables is $0.02 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price